Aethlon Medical, Inc. (AEMD) Cash Flow Statement

The tight correlation between net income and operating cash flow suggests that the company lacks non-cash operational levers to bridge its funding gap. Investors should monitor this relationship, as the inability to decouple cash burn from accounting losses underscores the fundamental reliance on external financing to sustain the business.

The lack of positive free cash flow is a direct consequence of the company's pre-revenue status and high fixed-cost clinical trial requirements. This trajectory suggests that the current cash runway is rapidly depleting, necessitating further scrutiny of the company's ability to reach pivotal clinical milestones before exhausting its remaining liquidity.

These fluctuations in working capital appear to be driven by the timing of vendor payments and clinical trial expenses rather than operational efficiency. The inconsistency in these figures warrants further investigation into the company's ability to manage its payables effectively as it approaches critical funding thresholds.